Brief: Evelo Biosciences Reports Third Quarter 2022 Financial Results, Business Highlights

Evelo Biosciences

14/11/2022 22:39

Nov 14 (Reuters) - Evelo Biosciences Inc  EVLO.O :
    * EVELO BIOSCIENCES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND BUSINESS HIGHLIGHTS
    * AS OF SEPTEMBER 30, 2022, CASH AND CASH EQUIVALENTS WERE
$69.1
MILLION
    * QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO COMMON
STOCKHOLDERS,
BASIC AND DILUTED $0.28
    * Q3 EARNINGS PER SHARE VIEW $-0.33 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX1dCDFP 
Further company coverage:  EVLO.O 
 ((Reuters.Briefs@thomsonreuters.com;))